Literature DB >> 25314357

Predicting C282Y homozygote genotype for hemochromatosis using serum ferritin and transferrin saturation values from 44,809 participants of the HEIRS study.

Andrew Lim, Mark Speechley, Paul C Adams.   

Abstract

INTRODUCTION: The simultaneous interpretation of serum ferritin level and transferrin saturation has been used as a clinical guide to diagnose genetic hemochromatosis. The Hemochromatosis and Iron Overload Screening (HEIRS) Study screened 101,168 North American participants for serum ferritin level and transferrin saturation, and C282Y genotyping for the HFE gene.
METHODS: Logistic regression involving a subsample of Caucasians (n=44,809) was used to predict individual probabilities of HFE C282Y homozygosity using serum ferritin and transferrin saturation values. Men (n=17,323) and women (n=27,486) were analyzed separately. Regression equations were evaluated using area under the curve from ROC analysis and variance explained by Nagelkerke's pseudo R-squared. An Android smartphone App and website application were developed to provide physicians with easy access to predicting C282Y homozygosity of the HFE gene.
RESULTS: The logistic equation had an area under the ROC curve of 0.91 for men and 0.89 for women. The pseudo R-squared was 0.44 for men and 0.34 for women. An example analysis was a Caucasian man with a transferrin saturation of 50% and a ferritin level of 500 µg⁄L, who had a 1.3% (95% CI 1.1% to 8.8%) probability of being a C282Y homozygote.
CONCLUSIONS: A large primary care-based sample of 44,809 participants contributed to the development of a new computer⁄smartphone tool that predicts the probability of being a C282Y homozygote of the HFE gene from serum ferritin and transferrin saturation values.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25314357      PMCID: PMC4205907          DOI: 10.1155/2014/698352

Source DB:  PubMed          Journal:  Can J Gastroenterol Hepatol        ISSN: 2291-2789


  9 in total

1.  Transferrin saturation as a predictor of hepatic iron overload.

Authors:  Paul C Adams; Melanie D Beaton
Journal:  Liver Int       Date:  2010-08-25       Impact factor: 5.828

2.  Comparison of the unsaturated iron-binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101,168 participants in the hemochromatosis and iron overload screening (HEIRS) study.

Authors:  Paul C Adams; David M Reboussin; Cathie Leiendecker-Foster; Godfrey C Moses; Gordon D McLaren; Christine E McLaren; Fitzroy W Dawkins; Ishmael Kasvosve; Ron T Acton; James C Barton; Dan Zaccaro; Emily L Harris; Richard Press; Henry Chang; John H Eckfeldt
Journal:  Clin Chem       Date:  2005-04-15       Impact factor: 8.327

3.  Hereditary hemochromatosis: missed diagnosis or misdiagnosis?

Authors:  Cynthia E Cherfane; Ryan D Hollenbeck; Jorge Go; Kyle E Brown
Journal:  Am J Med       Date:  2013-09-18       Impact factor: 4.965

4.  Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study.

Authors:  Paul C Adams; Mark Speechley; James C Barton; Christine E McLaren; Gordon D McLaren; John H Eckfeldt
Journal:  Hepatology       Date:  2012-04-18       Impact factor: 17.425

5.  Hemochromatosis and Iron Overload Screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults.

Authors:  Christine E McLaren; James C Barton; Paul C Adams; Emily L Harris; Ronald T Acton; Nancy Press; David M Reboussin; Gordon D McLaren; Phyliss Sholinsky; Ann P Walker; Victor R Gordeuk; Catherine Leiendecker-Foster; Fitzroy W Dawkins; John H Eckfeldt; Beverly G Mellen; Mark Speechley; Elizabeth Thomson
Journal:  Am J Med Sci       Date:  2003-02       Impact factor: 2.378

6.  Hemochromatosis and iron-overload screening in a racially diverse population.

Authors:  Paul C Adams; David M Reboussin; James C Barton; Christine E McLaren; John H Eckfeldt; Gordon D McLaren; Fitzroy W Dawkins; Ronald T Acton; Emily L Harris; Victor R Gordeuk; Catherine Leiendecker-Foster; Mark Speechley; Beverly M Snively; Joan L Holup; Elizabeth Thomson; Phyliss Sholinsky
Journal:  N Engl J Med       Date:  2005-04-28       Impact factor: 91.245

7.  Biological variability of transferrin saturation and unsaturated iron-binding capacity.

Authors:  Paul C Adams; David M Reboussin; Richard D Press; James C Barton; Ronald T Acton; Godfrey C Moses; Catherine Leiendecker-Foster; Gordon D McLaren; Fitzroy W Dawkins; Victor R Gordeuk; Laura Lovato; John H Eckfeldt
Journal:  Am J Med       Date:  2007-11       Impact factor: 4.965

8.  A nomogram to predict C282Y hemochromatosis.

Authors:  Jerry S McGrath; Yves Deugnier; Romain Moirand; Anne-Marie Jouanolle; Subrata Chakrabarti; Paul C Adams
Journal:  J Lab Clin Med       Date:  2002-07

9.  Genetic screening for iron overload: No evidence of discrimination at 1 year.

Authors:  Mark A Hall; James C Barton; Paul C Adams; Christine E McLaren; Jacob A Reiss; Oswaldo Castro; Andrea Ruggiero; Ronald T Acton; Tara E Power; Thomas C Bent
Journal:  J Fam Pract       Date:  2007-10       Impact factor: 0.493

  9 in total
  1 in total

1.  An efficient machine learning-based approach for screening individuals at risk of hereditary haemochromatosis.

Authors:  Patricia Martins Conde; Thomas Sauter; Thanh-Phuong Nguyen
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.